Novel ternary vanadium-betaine-peroxido species suppresses H-ras and matrix metalloproteinase-2 expression by increasing reactive oxygen species-mediated apoptosis in cancer cells

Cancer Letters

Volumn 335, Issue 2, 2013, Pages 387-396

  Petanidis, Savvas ^a   Kioseoglou, Efrosini ^a   Hadzopoulou Cladaras, Margarita ^b   Salifoglou, Athanasios ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Anti tumor properties; Breast and lung cancer cells; Signaling; Tumor suppression; Vanadium betaine peroxido species

Indexed keywords

GELATINASE A; GUANINE NUCLEOTIDE BINDING PROTEIN; H RAS PROTEIN; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; VANADIUM DERIVATIVE; VANADIUM PEROXIDOBETAINE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ISOLATION; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TARGETING; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ADENOCARCINOMA; APOPTOSIS; BETAINE; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DNA DAMAGE; FEMALE; HUMANS; LUNG NEOPLASMS; MATRIX METALLOPROTEINASE 2; MCF-7 CELLS; PEROXIDES; PROTO-ONCOGENE PROTEINS P21(RAS); REACTIVE OXYGEN SPECIES; VANADIUM;

EID: 84878214883     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2013.02.052     Document Type: Article

References (54)

1. Mukherjee B., Patra B., Mahapatra S., Banerjee P., Tewari A., Chatterjee M. Vanadium - an element of a typical biological significance. Toxicol. Lett. 2004, 150:135-143.
2. Nriagu J.O. History occurrence and uses of vanadium. Vanadium in the Environment 1998, 1-24. Wiley Interscience, New York. J.O. Nriagu (Ed.).
3. Barceloux D.G. Vanadium. J. Toxicol. Clin. Toxicol. 1999, 37:265-278.
4. Elberg G., Li J., Shechter Y. Mechanism of action of vanadium in mediating the biological effects of insulin. Vanadium in the Environment, Part 2 1998, 277-296. Wiley Interscience, New York. J.O. Nriagu (Ed.).
5. Tsiani E., Fantus I.G. Vanadium compounds: biological actions and potential as pharmacological agents. Trends Endocrinol. Metab. 1997, 8:51-58.
6. Stern A., Yin X., Tsang S.S., Davidson A., Moon A.J. Vanadium as a modulator of cellular regulatory cascades and oncogene expression. Biochem. Cell. Biol. 1993, 71:103-112.
7. Oliva J., Zhong J., Buslon V.S., French S.W. The effect of SAMe and betaine on Hepa 1-6, C34 and E47 liver cell survival in vitro. Exp. Mol. Pathol. 2012, 92:126-130.
8. Yi E.Y., Kim Y.J. Betaine inhibits invitro and invivo angiogenesis through suppression of the NF-κB and Akt signaling pathways. Int. J. Oncol. 2012, 41:1879-1885.
9. Go E.K., Jung K.J., Kim J.Y., Yu B.P., Chung H.Y. Betaine suppresses proinflammatory signaling during aging: the involvement of nuclear factor-kappaB via nuclear factor-inducing kinase/IkappaB kinase and mitogen-activated protein kinases. J. Gerontol. A Biol. Sci. Med. Sci. 2005, 60:1252-1264.
10. Go E.K., Jung K.J., Kim J.M., Lim H., Lim H.K., Yu B.P., Chung H.Y. Betaine modulates age-related NF-kappaB by thiol-enhancing action. Biol. Pharm. Bull. 2007, 30:2244-2249.
11. Griffiths J.R., McSheehy P.M., Robinson S.P., Troy H., Chung Y.L., Leek R.D., Williams K.J., Stratford I.J., Harris A.L., Stubbs M. Metabolic changes detected by in vivo magnetic resonance studies of HEPA-1 wild-type tumors and tumors deficient in hypoxia-inducible factor-1beta (HIF-1beta): evidence of an anabolic role for the HIF-1 pathway. Cancer Res. 2002, 62:688-695.
12. Forestier M., Bänninger R., Reichen J., Solioz M. Differentially expressed genes in cirrhosis: betaine - homocysteine methyltransferase (BHMT) is reduced in bile duct ligated rat liver. J. Hepatol. 1998, 28(Suppl.):86.
13. Abdelmalek M.F., Angulo P., Jorgensen R.N., Sylvestre P.B., Lindor K.D. Betaine, a promising new agent for patients with nonalcoholic steatohepatitis: results of a pilot study. Am. J. Gastroenterol. 2001, 96:2711-2717.
14. Schneider C.J., Penner-Hahn J.E., Pecoraro V.L. Elucidating the protonation site of vanadium peroxide complexes and the implications for biomimetric catalysis. J. Am. Chem. Soc. 2008, 130:2712-2713.
15. Gabriel C., Kaliva M., Venetis J., Baran P., Rodriguez-Escudero I., Voyiatzis G., Zervou M., Salifoglou A. Aqueous V(V)-peroxo-amino acid chemistry. Synthesis, structural and spectroscopic characterization of unusual ternary dinuclear tetraperoxo vanadium(V)-glycine complexes. Inorg. Chem. 2009, 48:476-487.
16. Djordjevic C., Wampler G.L. Antitumor activity and toxicity of peroxo heteroligand vanadates (V) in relation to biochemistry of vanadium. J. Inorg. Biochem. 1985, 25:51-55.
17. Gabriel C., Kioseoglou E., Venetis J., Psycharis V., Raptopoulou C.P., Terzis A., Voyiatzis G., Bertmer M., Mateescu C., Salifoglou A. pH-specific structural speciation of the ternary V(V)-peroxido-betaine system: a chemical reactivity-structure correlation. Inorg. Chem. 2012, 51:6056-6069.
18. Devereux T.R., Holliday W., Anna C., Ress N., Roycroft J., Sills R.C. Map kinase activation correlates with K-ras mutation and loss of heterozygosity on chromosome 6 in alveolar bronchiolar carcinomas from B6C3F1 mice exposed to vanadium pentoxide for 2years. Carcinogenesis 2002, 23:1737-1743.
19. Zhang Z., Huang C., Li J., Leonard S.S., Lanciotti R., Butterworth L., Shi X. Vanadate-induced cell growth regulation and the role of reactive oxygen species. Arch. Biochem. Biophys. 2001, 392:311-320.
20. Navara C.S., Benyumov A., Vassilev A., Narla R.K., Ghosh P., Uckun F.M. Vanadocenes as potent anti-proliferative agents disrupting mitotic spindle formation in cancer cells. Anticancer Drugs 2001, 4:369-376.
21. Assem F.L., Levy L.S. A review of current toxicological concerns on vanadium pentoxide and other vanadium compounds: gaps in knowledge and directions for future research. J. Toxicol. Environ. Health B Crit. Rev. 2009, 12:289-306.
22. Jungwirth U., Kowol C.R., Keppler B.K., Hartinger C.G., Berger W., Heffeter P. Anticancer activity of metal complexes: involvement of redox processes. Antioxid. Redox Signal 2011, 15:1085-1127.
23. Fu Y., Wang Q., Yang X.-G., Yang X.-D., Wang K. Vanadyl bisacetylacetonate induced G1/S cell cycle arrest via high-intensity ERK phosphorylation in HepG2 cells. J. Biol. Inorg. Chem. 2008, 13:1001-1009.
24. Zhang Z., Huang C., Li J., Shi X. Vanadate-induced cell growth arrest is p53-dependent through activation of p21 in C141 cells. J. Inorg. Biochem. 2002, 89:142-148.
25. Rondini E.A., Walters D.M., Bauer A.K. Vanadium pentoxide induces pulmonary inflammation and tumor promotion in a strain-dependent manner. Part Fibre Toxicol. 2010, 7:1-13.
26. Nowsheen S., Aziz K., Kryston T.B., Ferguson N.F., Georgakilas A. The interplay between inflammation and oxidative stress in carcinogenesis. Curr. Mol. Med. 2012, 12:672-680.
27. Chakraborty T., Chatterjee A., Rana A., Rana B., Palanisamy A., Madhappan R., Chatterjee M. Suppression of early stages of neoplastic transformation in a two-stage chemical hepatocarcinogenesis model: supplementation of vanadium, a dietary micronutrient, limits cell proliferation and inhibits the formations of 8-hydroxy-2'-deoxyguanosines and DNA strand-breaks in the liver of Sprague-Dawley rats. Nutr. Cancer 2007, 59:228-247.
28. kip1 and Cdk2/SHP-1 complex formation in human ovarian cancer cells. Cancer Lett. 2008, 262:265-275.
29. Evangelou A.M. Vanadium in cancer treatment. Crit. Rev. Oncol. Hematol. 2002, 42:249-265.
30. Jaspers I., Samet J.M., Erzurum S., Reed W. Vanadium-induced kappaB-dependent transcription depends upon peroxide-induced activation of the p38 mitogen-activated protein kinase. Am. J. Respir. Cell Mol. Biol. 2000, 23:95-102.
31. Chien P.S., Mak O.T., Huang H.J. Induction of COX-2 protein expression by vanadate in A549 human lung carcinoma cell line through EGF receptor and p38 MAPK-mediated pathway. Biochem. Biophys. Res. Commun. 2006, 339:562-568.
32. Ouellet M., Roy J., Barbeau B., Geleziunas R., Tremblay M.J. NF-kappaB induction by bisperoxovanadium compounds requires CD45, p36(LAT), PKC, and IKK activity and exhibits kinetics of activation comparable to those of TCR/CD28 coengagement. Biochemistry 2003, 42:8260-8271.
33. Zhang Z., Chen F., Huang C., Shi X. Vanadate induces G2/M phase arrest in p53-deficient mouse embryo fibroblasts. J. Environ. Pathol. Toxicol. Oncol. 2002, 21:223-231.
34. Zhao Y., Ye L., Liu H., Xia Q., Zhang Y., Yang X., Wang K. Vanadium compounds induced mitochondria permeability transition pore (PTP) opening related to oxidative stress. J. Inorg. Biochem. 2010, 104:371-378.
35. Anwar-Mohamed A., El-Kadi A.O. Down-regulation of the carcinogen-metabolizing enzyme cytochrome P450 1a1 by vanadium. Drug Metab. Dispos. 2008, 36:1819-1827.
36. Kataoka S., Yasui H., Hiromura M., Sakurai H. Effect of insulin-mimetic vanadyl sulfate on cytochrome P450 2E1-dependent p-nitrophenol hydroxylation in the liver microsomes of streptozotocin-induced type 1 diabetic rats. Life Sci. 2005, 77:2814-2829.
37. Ray R.S., Basu M., Ghosh B., Samanta K., Chatterjee M. Vanadium, a versatile biochemical effecter in chemical rat mammary carcinogenesis. Nutr. Cancer 2005, 51:184-196.
38. Thompson H.J., Chasteen N.D., Meeker L.D. Dietary vanadyl(IV) sulfate inhibits chemically-induced mammary carcinogenesis. Carcinogenesis 1984, 5:849-851.
39. Kostova I. Titanium and vanadium complexes as anticancer agents. Anticancer Agents Med. Chem. 2009, 9:827-842.
40. Bishayee A., Waghray A., Patel M.A., Chatterjee M. Vanadium in the detection, prevention and treatment of cancer: the in vivo evidence. Cancer Lett. 2010, 294:1-12.
41. Colín-Barenque L., Martínez-Hernández M.G., Baiza-Gutman L.A., Avila-Costa M.R., Ordóñez-Librado J.L., Bizarro-Nevares P., Rodriguez-Lara V., Piñón-Zarate G., Rojas-Lemus M., Mussali-Galante P., Fortoul T.I. Matrix metalloproteinases 2 and 9 in central nervous system and their modification after vanadium inhalation. J. Appl. Toxicol. 2008, 28:718-723.
42. López-Lázaro M. Dual role of hydrogen peroxide in cancer: possible relevance to cancer chemoprevention and therapy. Cancer Lett. 2007, 252:1-8.
43. Matés J.M., Sánchez-Jiménez F.M. Role of reactive oxygen species in apoptosis: implications for cancer therapy. Int. J. Biochem. Cell. Biol. 2000, 32:157-170.
44. Ray R.S., Rana B., Swami B., Venu V., Chatterjee M. Vanadium mediated apoptosis and cell cycle arrest in MCF7 cell line. Chem. Biol. Interact. 2006, 163:239-247.
45. Bishayee A., Oinam S., Basu M., Chatterjee M. Vanadium chemoprevention of 7,12-dimethylbenz(a)anthracene-induced rat mammary carcinogenesis: probable involvement of representative hepatic phases I and II xenobiotic metabolizing enzymes. Breast Cancer Res. Treat. 2000, 63:133-145.
46. 2 vitamin D3 combination in inhibitions of 1,2-dimethylhydrazine-induced rat colon carcinogenesis. Biochim. Biophys. Acta 2008, 1780:1106-1114.
47. Kibblewhite M.G., Van Rensburg S.J., Laker M.C., Rose E.F. Evidence for an intimate geochemical factor in the etiology of esophageal cancer. Environ. Res. 1984, 33:370-378.
48. Tang L.Y., Su Y., He J.R., Chen W.Q., Su F.X., Wu B.H., Lin Y., Ren Z.F. Urinary titanium and vanadium and breast cancer: a case-control study. Nutr. Cancer 2012, 64:368-376.
49. Yamaguchi T., Watanabe S., Matsumura Y., Tokuoka Y., Yokoyama A. Oxovanadium complexes with quinoline and pyridinone ligands: syntheses of the complexes and effect of alkyl chains on their apoptosis-inducing activity in leukemia cells. Bioorg. Med. Chem. 2012, 20:3058-3064.
50. Harding M.M., Mokdsi G. Antitumour metallocenes: structure-activity studies and interactions with biomolecules. Curr. Med. Chem. 2000, 7:1289-1303.
51. Kume S., Ueki T., Matsuoka H., Hamada M., Satoh N., Michibata H. Differential gene regulation by V(IV) and V(V) ions in the branchial sac, intestine, and blood cells of a vanadium-rich ascidian, Ciona intestinalis. Biometals 2012, 25:1037-1050.
52. Cohen M.D., Sisco M., Prophete C., Yoshida K., Chen L.C., Zelikoff J.T., Smee J., Holder A.A., Stonehuerner J., Crans D.S., Ghio A.J. Effects of metal compounds with distinct physicochemical properties on iron homeostasis and antibacterial activity in the lungs: chromium and vanadium. Inhal. Toxicol. 2010, 22:169-178.
53. Wang L., Medan D., Mercer R., Overmiller D., Leornard S., Castranova V., Shi X., Ding M., Huang C., Rojanasakul Y. Vanadium-induced apoptosis and pulmonary inflammation in mice: role of reactive oxygen species. J. Cell. Physiol. 2003, 195:99-107.
54. Ray R.S., Ghosh B., Rana A., Chatterjee M. Suppression of cell proliferation, induction of apoptosis and cell cycle arrest: chemopreventive activity of vanadium in vivo and in vitro. Int. J. Cancer 2007, 120:13-23.